SK

Sanjay Khurana

Active Director Director DIN 01055040
DIN 01055040 First appointment Apr 1990 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 7 historical roles
Total affiliations 10 Since Apr 1990
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Khurana

Data last updated:

Sanjay Khurana is a Director at Kemsyn Lifesciences Private Limited (since 2024), Director at Nitin Lifesciences Limited (since 2023) and Director at Synokem Pharmaceuticals Limited (since 2022). The companies operate in Paper, Pharma and Packaging. Earlier, Sanjay Khurana was a Director at Baddi Foils Private Limited (2005–2021) and Nominee Director at Shivalik Solid Waste Management Limited (2019–2022) and 5 more.

DIN 01055040
Primary Designation Director
Industry Paper
First Appointment 19 Apr 1990
Oldest Company Age 43 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kemsyn Lifesciences Private Limited U21002MH2024PTC435803
Director29 Nov 20242024Active
Nitin Lifesciences Limited U73100HP2005PLC028049
Director27 Sep 20232005Active
Synokem Pharmaceuticals Limited U21002DL1983PLC016353
Director10 Jan 20221983Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Baddi Foils Private Limited U27203DL2005PTC132573
Director02 Feb 20052005Active
Nominee Director16 Sep 20192005Active
Baddi Infrastructure U45209HP2010NPL031349
Director06 May 20102010Active
Director20 Aug 20102010Strike Off
G & S Vinyl Limited U74899DL2000PLC103732
Director01 Aug 20112000Active
Himachal Pradesh Kaushal Vikas Nigam U74999HP2015NPL001036
Nominee Director15 Jan 20162015Active
Classic Closures Private Limited U74899DL1990PTC039901
Director19 Apr 19901990Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Synokem Pharmaceuticals Limited
Kemsyn Lifesciences Private Limited
Nitin Lifesciences Limited
Classic Closures Private Limited
Premium access

Shareholding and investment profile for Sanjay Khurana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Khurana

Sanjay Khurana currently holds 3 directorships: Kemsyn Lifesciences Private Limited (Director, since 29 Nov 2024); Nitin Lifesciences Limited (Director, since 27 Sep 2023); Synokem Pharmaceuticals Limited (Director, since 10 Jan 2022).

Sanjay Khurana was first appointed on 19 Apr 1990 as Director at Classic Closures Private Limited. The most recent appointment on record is 29 Nov 2024 at Kemsyn Lifesciences Private Limited.

Sanjay Khurana held 7 earlier board appointments: Baddi Foils Private Limited (Director, 02 Feb 2005 to 20 Dec 2021); Shivalik Solid Waste Management Limited (Nominee Director, 16 Sep 2019 to 01 Feb 2022); Baddi Infrastructure (Director, 06 May 2010 to 02 Feb 2022); Baddi Innovations And Technologies Private Limited (Director, 20 Aug 2010 to 27 Sep 2013); G & S Vinyl Limited (Director, 01 Aug 2011 to 20 Dec 2021); and 2 more.

The current boards of Sanjay Khurana's companies include Abhinav Arora (Kemsyn Lifesciences Private Limited), Rajan Mahendru (Kemsyn Lifesciences Private Limited), Sunil Kumar Kothari (Kemsyn Lifesciences Private Limited), Thomas Baby (Kemsyn Lifesciences Private Limited), Vishal Kumar (Kemsyn Lifesciences Private Limited), Pradhyuman Singh Yadav (Nitin Lifesciences Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available